Bumper Offer - Urjas oil Just @ Rs. 1
Zimigut 400 Tablet is a commercial drug that is prescribed in the form of Tablet. Hepatic Encephalopathy are some of its major therapeutic uses. Zimigut 400 Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Zimigut 400 Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Common side effects of Zimigut 400 Tablet include Flatulence, Bloating or fullness, Constipation. While these are the most often observed Zimigut 400 Tablet side effects, there are can be others also. These have been listed below. These side effects of Zimigut 400 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Zimigut 400 Tablet's effect is Severe during pregnancy and Severe for lactating mothers. Warnings related to Zimigut 400 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Other conditions have been mentioned below in the Zimigut 400 Tablet contraindications section.
Besides this, Zimigut 400 Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Zimigut 400 Tablet is safe while driving, and is is addictive in nature.
Zimigut 400 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Zimigut 400 Tablet is used -
Moderate
Mild
Common
Is the use of Zimigut 400 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Zimigut. If you are pregnant, do not take Zimigut without a doctor's advice.
Is the use of Zimigut 400 Tablet safe during breastfeeding?
Zimigut may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Zimigut 400 Tablet on the Kidneys?
Zimigut is completely safe for kidneys.
What is the effect of Zimigut 400 Tablet on the Liver?
Zimigut may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Zimigut 400 Tablet on the Heart?
Zimigut is completely safe for the heart.
Zimigut 400 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Zimigut 400 Tablet unless your doctor advises you to do so -
Is this Zimigut 400 Tablet habit forming or addictive?
Forming a habit of Zimigut 400 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Zimigut 400 Tablet since it will not make you feel sleepy.
Is it safe?
Yes, Zimigut 400 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Zimigut 400 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Zimigut 400 Tablet
You can take Zimigut 400 Tablet with food.
Interaction between Alcohol and Zimigut 400 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Zimigut 400 Tablet with alcohol will be.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097